Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement activation after aortic endothelial injury.

P S Seifert, J L Catalfamo, J Dodds

    Seminars in Thrombosis and Hemostasis
    |October 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Prediction of stillbirth: an umbrella review of evaluation of prognostic variables.

    BJOG : an international journal of obstetrics and gynaecology·2020
    Same author

    BRIEF - SYNOPSIS OF THE HUMAN IMMUNODEFICIENCY VIRUS (HIV) SCREENING AND TESTING GUIDE.

    Canada communicable disease report = Releve des maladies transmissibles au Canada·2019
    Same author

    Effects of oral probiotic supplements on vaginal microbiota during pregnancy: a randomised, double-blind, placebo-controlled trial with microbiome analysis.

    BJOG : an international journal of obstetrics and gynaecology·2019
    Same author

    New resources to address antibiotic resistance are just a click away.

    Canada communicable disease report = Releve des maladies transmissibles au Canada·2018
    Same author

    A TMEM16F point mutation causes an absence of canine platelet TMEM16F and ineffective activation and death-induced phospholipid scrambling.

    Journal of thrombosis and haemostasis : JTH·2015
    Same author

    Non-anaemic iron deficiency in pregnancy: the views of health service users and health care professionals.

    Transfusion medicine (Oxford, England)·2015
    Same journal

    Bridging the Gap in Laboratory Monitoring of Extended Half-Life Factor VIII and IX: Can Thrombin Generation Assays Overcome Assay Discrepancies?

    Seminars in thrombosis and hemostasis·2026
    Same journal

    External Quality Assessment for Low Molecular Weight Heparin Monitoring in the Australasia/Asia-Pacific Region.

    Seminars in thrombosis and hemostasis·2026
    Same journal

    Human evolution: between hemorrhage and thrombosis.

    Seminars in thrombosis and hemostasis·2026
    Same journal

    Full- vs Reduced-Dose Direct Oral Anticoagulants for Extended Treatment of Cancer-Associated Thrombosis: A Multicenter Retrospective Cohort Study.

    Seminars in thrombosis and hemostasis·2026
    Same journal

    Too Old for PESI?: Risk Stratification of Octogenarians with Pulmonary Embolism in the Emergency Department.

    Seminars in thrombosis and hemostasis·2026
    Same journal

    Acute Management and Bleeding Outcomes in Pediatric Pulmonary Embolism: A Large Single-Center Retrospective Cohort Study.

    Seminars in thrombosis and hemostasis·2026
    See all related articles

    Ischemic endothelial cell injury activates complement (C) via the classic pathway, potentially explaining inflammation in infarcted tissues. Complement activation products like C3a and C5a may drive these inflammatory changes.

    Area of Science:

    • Immunology
    • Vascular Biology
    • Pathophysiology

    Background:

    • Endothelial cell injury is a hallmark of ischemic events.
    • Complement system activation is implicated in inflammatory processes.
    • The specific role of complement in ischemia-induced endothelial injury requires elucidation.

    Purpose of the Study:

    • To investigate the role of complement (C) activation in ischemic endothelial cell injury.
    • To determine the pathway involved in complement activation during ischemia.
    • To explore the contribution of complement activation products to inflammation in infarcted tissues.

    Main Methods:

    • Studied complement activation following ischemic endothelial cell injury.
    • Investigated the involvement of the classic complement pathway.

    Related Experiment Videos

  • Analyzed the generation of complement activation products (C3a, C5a).

    • Main Results:

    • Ischemic endothelial cell injury triggers complement (C) activation.
    • Complement activation predominantly occurs via the classic pathway.
    • Complement activation products, including C3a and C5a, are generated.

    Conclusions:

    • Complement (C) activation, initiated via the classic pathway, is a consequence of ischemic endothelial cell injury.
    • Generated complement activation products (C3a, C5a) likely mediate inflammatory responses in infarcted tissues.
    • Findings are relevant to clinical scenarios involving ischemia, such as embolization and thrombus formation.